XNAS
EXPO
Market cap2.96bUSD
Jul 09, Last price
62.17USD
1D
2.00%
1Q
-4.90%
Jan 2017
106.20%
Name
Exponent Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑00 | 2025‑00 | 2023‑12 | 2023‑12 | 2022‑12 | 2022‑12 | 2021‑12 | 2021‑00 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2018‑12 | 2017‑12 | 2017‑12 | 2016‑12 | 2016‑12 | |
| Income | |||||||||||||||||
Revenues | |||||||||||||||||
Cost of revenue | |||||||||||||||||
Unusual Expense (Income) | |||||||||||||||||
NOPBT | |||||||||||||||||
NOPBT Margin | |||||||||||||||||
Operating Taxes | |||||||||||||||||
Tax Rate | |||||||||||||||||
NOPAT | |||||||||||||||||
Net income | |||||||||||||||||
Dividends | |||||||||||||||||
Dividend yield | |||||||||||||||||
Proceeds from repurchase of equity | |||||||||||||||||
BB yield | |||||||||||||||||
| Debt | |||||||||||||||||
Debt current | |||||||||||||||||
Long-term debt | |||||||||||||||||
Deferred revenue | |||||||||||||||||
Other long-term liabilities | |||||||||||||||||
Net debt | |||||||||||||||||
| Cash flow | |||||||||||||||||
Cash from operating activities | |||||||||||||||||
CAPEX | |||||||||||||||||
Cash from investing activities | |||||||||||||||||
Cash from financing activities | |||||||||||||||||
FCF | |||||||||||||||||
| Balance | |||||||||||||||||
Cash | |||||||||||||||||
Long term investments | |||||||||||||||||
Excess cash | |||||||||||||||||
Stockholders' equity | |||||||||||||||||
Invested Capital | |||||||||||||||||
ROIC | |||||||||||||||||
ROCE | |||||||||||||||||
| EV | |||||||||||||||||
Common stock shares outstanding | |||||||||||||||||
Price | |||||||||||||||||
Market cap | |||||||||||||||||
EV | |||||||||||||||||
EBITDA | |||||||||||||||||
EV/EBITDA | |||||||||||||||||
Interest | |||||||||||||||||
Interest/NOPBT | |||||||||||||||||